PODESTA GROUP, INC. for GENZYME
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient Protection and Affordable Care Act implementation. 340B issues Monitor debt ceiling negotiations, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Line 27, has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
| ANNE MARIE POLAK | — |
| OSCAR RAMIREZ | — |
Medicare/Medicaid MMM
Medicare issues related to end stage renal disease. Monitor debt ceiling negotiations, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011.
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Line 27, has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| ANTHONY PODESTA | — |
| ANNE MARIE POLAK | — |
| OSCAR RAMIREZ | — |
Budget/Appropriations BUD
FY 2011 and 2012 budget appropriations. Monitor debt ceiling negotiations, generally. H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act of 2011.
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Line 27, has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Pharmacy PHA
Prescription Drug User Fee Act reauthorization.
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Line 27, has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Copyright/Patent/Trademark CPT
H.R. 1249 / S. 23, America Invents Act.
Foreign entity interest: As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Line 27, has an interest in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SANOFI SA | France | France | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.